scholarly journals Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2021 ◽  
Vol 397 (10275) ◽  
pp. 682-694 ◽  
Author(s):  
Peter Richmond ◽  
Lara Hatchuel ◽  
Min Dong ◽  
Brenda Ma ◽  
Branda Hu ◽  
...  
Keyword(s):  
Subunit Vaccine ◽  
Vaccine Candidate ◽  
Controlled Trial ◽  
Phase 1 ◽  
Healthy Adults ◽  
Protein Subunit ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Immuno-enhancement effects of Korean Red Ginseng in healthy adults: a randomized, double-blind, placebo-controlled trial

2021 ◽  
Vol 45 (1) ◽  
pp. 191-198
Author(s):  
Sun Hee Hyun ◽  
Ha-Young Ahn ◽  
Hyeong-Jun Kim ◽  
Sung Won Kim ◽  
Seung-Ho So ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Healthy Adults ◽  
Red Ginseng ◽  
Korean Red Ginseng ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

2016 ◽  
Vol 16 (3) ◽  
pp. 311-320 ◽  
Author(s):  
Olga De Santis ◽  
Régine Audran ◽  
Emilie Pothin ◽  
Loane Warpelin-Decrausaz ◽  
Laure Vallotton ◽  
...  
Keyword(s):  
Phase 1 ◽  
Healthy Adults ◽  
Dose Finding ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document